This activity is designed to change: Competence, Performance, Patient Outcomes. 5 hr(s)
After completing this activity participants will be able to:
- Assess for risk of substance use disorders in patients being considered for treatment with opioids (including ER/LA opioids).
- Become knowledgeable about the general and specific characteristics of opioids including the effect of tolerance on prescribing for patients and learn differences with ER/LA opioids before prescribing them.
- Safely and effectively initiate treatment using opioids, only when it is indicated, based on a complete history and physical examination and assessment of patient pain and functioning.
- Use effective communication techniques with patients and their caregivers when opioids are prescribed for chronic pain to support their safe use at the minimum dose needed and help prevent adverse effects and diversion.
- Monitor patients on chronic opioid therapy, make appropriate referrals and safely discontinue medication use when indicated.
Modules in this Training Activity
Audience and Accreditation
Audience: Prescribers of ER/LA opioids and other health professionals who impact patients taking these medications
|AMA PRA Category 1 Credit(s)™||5 hr(s)||04/08/20||04/09/21|
Accreditation Statement: Clinical Tools, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit™ Designation Statement: Clinical Tools, Inc. designates this enduring material for a maximum of 5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A letter of completion for 5 hour(s) is available for non-physicians.
A score of 70% on the post-test is required to complete the activity.
Initial development of this activity was supported by a grant from the National Institute on Drug Abuse (#1R44DA027245-01), a contract from the National Institute on Drug Abuse (#HHSN271200800012C).
Most Recent Reviews
CTI Content Review: Wednesday, 04/01/2020
CTI Editorial Review: Monday, 04/06/2020